Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (91-100 of 277) with videos related to

Pageof 28
Sort By:
Blood Advances|March 22, 2022
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening methodCeline M Vachon, Josiah Murray, Cristine Allmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
American Journal of Human Genetics|May 22, 2002
Analysis of the RNASEL gene in familial and sporadic prostate cancerLiang Wang, Shannon K McDonnell, David A Elkins, et al.
The Journal of Experimental Medicine|November 3, 2010
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand, Zhenghua Luo, Michelle K Manske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemiaTait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Blood Neoplasia|June 2, 2025
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemiaOlivia M Depies, Qianqian Guo, Yuan Gao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Cancer|April 9, 2014
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesTimothy G Call, Aaron D Norman, Curtis A Hanson, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
Pageof 28

Showing results (91-100 of 277) with videos related to

Sort By:
Pageof 28
Blood Advances|March 22, 2022
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening methodCeline M Vachon, Josiah Murray, Cristine Allmer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2012
A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 regionJames R Cerhan, Zachary S Fredericksen, Anne J Novak, et al.
American Journal of Human Genetics|May 22, 2002
Analysis of the RNASEL gene in familial and sporadic prostate cancerLiang Wang, Shannon K McDonnell, David A Elkins, et al.
The Journal of Experimental Medicine|November 3, 2010
A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signalingJoanne M Hildebrand, Zhenghua Luo, Michelle K Manske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemiaTait D Shanafelt, Neil E Kay, Kari G Rabe, et al.
Blood Neoplasia|June 2, 2025
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemiaOlivia M Depies, Qianqian Guo, Yuan Gao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphomaJames R Cerhan, Wen Liu-Mares, Zachary S Fredericksen, et al.
Cancer|April 9, 2014
Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelinesTimothy G Call, Aaron D Norman, Curtis A Hanson, et al.
Ejhaem|October 17, 2024
Medical history and lifestyle factors have limited impact on time-to-first-treatment in patients with chronic lymphocytic leukemiaIngrid Glimelius, Geffen Kleinstern, Dennis P Robinson, et al.
Pageof 28